Improved diagnostic accuracy of planar imaging with technetium 99m-labeled tetrofosmin compared with thallium-201 for the detection of coronary artery disease

Journal of Nuclear Cardiology

Volumn 4, Issue 4, 1997, Pages 291-297

  Khattar, Rajdeep S ^b   Hendel, Robert C ^b   Crawley, John C W ^b   Wackers, Frans J ^b   Rigo, Pierre ^b   Zaret, Barry L ^b   Sridhara, Bangalore S ^b   Lahiri, Avijit ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Coronary artery disease; Receiver operating characteristic curve analysis; Technetium 99m labeled tetrofosmin; Thallium 201

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 0030772156     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90106-9     Document Type: Article

References (28)

1. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging: relation of thallium-201 to regional myocaridal perfusion. Circulation 1975;51:641-5.
2. Okada RG, Boucher CA, Strauss HW, Pohost GM. Exercise radionuclide imaging approaches to coronary artery disease. Am J Cardiol 1980;46:1188-204.
3. 99mTc methoxyisobutyl isonitrile with thallium-201 imaging by planar and SPECT techniques for assessment of coronary artery disease. Am Heart J 1989;117:1-11.
4. Berman DS. Introduction: technetium-99m myocardial perfusion imaging agents and their relation to thallium-201. Am J Cardiol 1990;66:1E-4E.
5. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7.
6. Higley B, Smith FW, Smith T, Gemmell HG, Gupta PD, Gvozdanovic DV, et al. Technetium-99m - 1,2 {bis(2-ethoxyethyl)phosphine} ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.
7. Sridhara BS, Braat S, Itti R, Rigo P, Cload P, Lahiri A. Early and late myocardial imaging with a new technetium-99m diphosphine (PPN 1011) in coronary artery disease [abstract]. J Am Coll Cardiol 1992;19:202A.
8. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72:1015-9.
9. Sridhara B, Sochor H, Rigo P, et al. Myocardial single-photon emission computed tomographic imaging with technetium 99m tetrofosmin: stress-rest imaging with same-day and separate-day rest imaging. J Nucl Cardiol 1994;1:138-43.
10. Jain D, Lahiri A, Raftery EB. Clinical and prognostic significance of lung thallium uptake in acute myocardial infarction. Am J Cardiol 1990;65:154-9.
11. Lusted LB. Decision making studies in patient management. N Engl J Med 1971;284:416-24.
12. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98.
13. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313-9.
14. Swets JA, Pickett RM. Evaluation of diagnostic systems: methods from signal detection theory. New York: Academic Press, 1982.
15. Hanley JA. The robustness of the 'binormal' assumptions used in fitting ROC curves. Med Decis Making 1988;8:197-203.
16. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley & Sons, 1975:9-11.
17. McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975;293:211-5.
18. Turner DA. An intuitive approach to receiver operating characteristic curve analysis. J Nucl Med 1978;19:213-20.
19. Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39/4:561-77.
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
21. Ladenheim MC, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71.
22. Hendel RC, Parker MA, Wackers FJT, Rigo P, Lahiri A, Zaret BL. Reduced variability of interpretation and improved image quality with a technetium-99m myocardial perfusion agent: comparison of thallium-201 and technetium-99m labelled tetrofosmin. J Nucl Cardiol 1994;1:509-14.
23. Allman KC, Berry J, Sucharski LA, et al. Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress. J Nucl Med 1992;33:2067-73.
24. Stewart RE, Markus S, Mohin E, Popma J, Gacioch GM, Kalus M, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67:1303-10.
25. Iskandrian AS, Heo J, Askenase A, Segal BL, Helfant RH. Thallium imaging with single-photon emission computed tomography. Am Heart J 1987;114:852-65.
26. Maublant J, Cassasgnes J, Jourde M, Veyre A, Meyniel G. Myocardial emission tomography with thallium-201. Eur J Nucl Med 1981;6:289-94.
27. Kirsh CM, Doliwa RA, Buell U, Roedler D. Detection of severe coronary heart disease with Tl-201: comparison of resting single-photon emission tomography with invasive arteriography. J Nucl Med 1983;24:761-7.
28. Tamaki N, Mukai T, Ishii Y, Yonekara Y, Kambara H, Kawai C, et al. Clinical evaluation of thallium-201 emission myocardial tomography using a rotating gamma camera: comparison with seven-pinhole tomography. J Nucl Med 1981;22:849-55.